Evidence map›Paper›PMID 40937047›Full record

ArticleThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale2025

The Inhibitory Effect of Niosome Containing Myrtenol as an Innovative Approach to Combat Methicillin-Resistant

Jaber Hemmati, Mohsen Chiani, Babak Asghari, Ghodratollah Roshanaei, Sara Soleimani Asl, Morvarid Shafiei, Mohammad Reza Arabestani

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jaber HemmatiDepartment of Microbiology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.ORCID https://orcid.org/0000-0003-3539-2238
Mohsen ChianiDepartment of NanoBiotechnology, Pasteur Institute of Iran, Tehran, Iran.ORCID https://orcid.org/0000-0001-6413-8752
Babak AsghariDepartment of Microbiology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.ORCID https://orcid.org/0000-0002-4038-9618
Ghodratollah RoshanaeiDepartment of Biostatistics, School of Medicine, Arak University of Medical Sciences, Arak, Iran.ORCID https://orcid.org/0000-0002-3547-9125
Sara Soleimani AslAnatomy Department, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.ORCID https://orcid.org/0000-0003-1518-3308
Morvarid ShafieiDepartment of Bacteriology, Pasteur Institute of Iran, Tehran, Iran.ORCID https://orcid.org/0000-0002-6166-5028
Mohammad Reza ArabestaniDepartment of Microbiology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.ORCID https://orcid.org/0000-0001-9991-8193

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The clinical challenge of staphylococcal treatment is increasing globally, making it critical to find effective strategies to hinder the spread of resistant isolates, particularly methicillin-resistant

Indexed as

biofilmdrug delivery systemmethicillin-resistant Staphylococcus aureus (MRSA)myrtenolniosomeresistant wound infection

Identifiers

PMID40937047
PMCPMC12422854

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.